Black Diamond Therapeutics Inc (BDTX) earnings · rev $70.0M
These earnings events as JSON? API free 100/dayBlack Diamond Therapeutics Inc (BDTX) is a biotechnology company listed on NASDAQ.
This BDTX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported BDTX revenue for 2025-12-31 was $70.0M. Net income was $22.4M. BDTX currently screens at market cap $95.7M.
When the next BDTX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for BDTX. We will not invent a beat or miss.
Not investment advice. Full BDTX research stays on the stock page; the tape stays on the quote page.
BDTX earnings FAQ
What are BDTX's latest revenue and net income?
Latest cached Black Diamond Therapeutics Inc (BDTX) revenue for Dec 31, 2025 was $70.0M. Net income was $22.4M. Statements: https://lician.com/financials/bdtx
What is BDTX's latest diluted EPS?
Latest cached Black Diamond Therapeutics Inc (BDTX) diluted EPS for Dec 31, 2025 was $0.39.
What period does the latest BDTX earnings print cover?
The latest cached Black Diamond Therapeutics Inc (BDTX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
Where are BDTX earnings listed?
Cached earnings facts for Black Diamond Therapeutics Inc (BDTX) are listed at https://lician.com/earnings/bdtx. Statements: https://lician.com/financials/bdtx
Not investment advice.